Peer Review reports
From: MiR-335 promotes corneal neovascularization by Targeting EGFR
| Original Submission | ||
|---|---|---|
| 22 Feb 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 19 Mar 2022 | Reviewed | Reviewer Report - Mona Abdelkader |
| 25 Mar 2022 | Reviewed | Reviewer Report |
| 8 Apr 2022 | Author responded | Author comments - Shu Liang |
| Resubmission - Version 3 | ||
| 8 Apr 2022 | Submitted | Manuscript version 3 |
| 15 May 2022 | Author responded | Author comments - Shu Liang |
| Resubmission - Version 4 | ||
| 15 May 2022 | Submitted | Manuscript version 4 |
| 18 May 2022 | Author responded | Author comments - Shu Liang |
| Resubmission - Version 5 | ||
| 18 May 2022 | Submitted | Manuscript version 5 |
| 21 May 2022 | Author responded | Author comments - Shu Liang |
| Resubmission - Version 6 | ||
| 21 May 2022 | Submitted | Manuscript version 6 |
| Publishing | ||
| 23 May 2022 | Editorially accepted | |
| 15 Jun 2022 | Article published | 10.1186/s12886-022-02481-0 |
You can find further information about peer review here.